ipragliflozin: Clinical Trials

4 completed. 4 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	4	Completed 4

Follow ipragliflozin: new trials by email Literature Review of ipragliflozin trials Research Report on ipragliflozin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy Ipragliflozin, Insulin - Type 2 Diabetes Mellitus	Phase 4	Completed	Astellas Pharma Inc	103	2016-07-29	2024-11-12
Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone Ipragliflozin, metformin with pioglitazone - Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)	Phase 4	Completed	Yonsei University	44	2016-04-26	2017-06-23
Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM) Ipragliflozin - Type 2 Diabetes Mellitus	Phase 4	Completed	Astellas Pharma Inc	100	2014-10-08	2024-11-08
A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus ipragliflozin, placebo - Type 2 Diabetes Mellitus	Phase 4	Completed	Astellas Pharma Inc	262	2014-03-31	2024-11-08

Conditions studied

Diabetes Mellitus, Type 2 (3)  ·  Diabetes Mellitus (1)  ·  Insulin Resistance (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Sponsors

Astellas Pharma Inc (3)  ·  Yonsei University (1)

Countries

Japan (3)  ·  South Korea (1)

Results publications

PMID 29926400, PMID 30800562, PMID 31552641, PMID 31606880